Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission
Clinical trial NCT02587871 · WITHDRAWN
Trial details
- NCT number
- NCT02587871
- Sponsor
- University of Southern California
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-12
- Primary completion
- 2020-11-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.